ZA200707413B - Cat allergen fusion proteins and uses thereof - Google Patents

Cat allergen fusion proteins and uses thereof

Info

Publication number
ZA200707413B
ZA200707413B ZA200707413A ZA200707413A ZA200707413B ZA 200707413 B ZA200707413 B ZA 200707413B ZA 200707413 A ZA200707413 A ZA 200707413A ZA 200707413 A ZA200707413 A ZA 200707413A ZA 200707413 B ZA200707413 B ZA 200707413B
Authority
ZA
South Africa
Prior art keywords
fusion proteins
cat allergen
allergen fusion
cat
proteins
Prior art date
Application number
ZA200707413A
Other languages
English (en)
Inventor
Bachmann Martin
Bauer Monika
Dietmeier Klaus
Schmitz Nicole
Utzinger Stephan
Original Assignee
Cytos Biotechnology Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytos Biotechnology Ag filed Critical Cytos Biotechnology Ag
Publication of ZA200707413B publication Critical patent/ZA200707413B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA200707413A 2005-03-18 2006-03-17 Cat allergen fusion proteins and uses thereof ZA200707413B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66291805P 2005-03-18 2005-03-18

Publications (1)

Publication Number Publication Date
ZA200707413B true ZA200707413B (en) 2009-01-28

Family

ID=36843236

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200707413A ZA200707413B (en) 2005-03-18 2006-03-17 Cat allergen fusion proteins and uses thereof

Country Status (19)

Country Link
US (3) US7767212B2 (pl)
EP (1) EP1868642B1 (pl)
JP (2) JP5302671B2 (pl)
KR (1) KR20070112225A (pl)
CN (2) CN101141979B (pl)
AU (1) AU2006224529B2 (pl)
BR (1) BRPI0608455A2 (pl)
CA (1) CA2599218C (pl)
CY (1) CY1114171T1 (pl)
DK (1) DK1868642T3 (pl)
ES (1) ES2424229T3 (pl)
IL (1) IL185103A0 (pl)
MX (1) MX2007011160A (pl)
NZ (1) NZ561040A (pl)
PL (1) PL1868642T3 (pl)
PT (1) PT1868642E (pl)
RU (1) RU2414239C2 (pl)
WO (1) WO2006097530A2 (pl)
ZA (1) ZA200707413B (pl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7320793B2 (en) * 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
AU2002339224B2 (en) 2001-09-14 2008-10-09 Kuros Us Llc Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
AU2003246690B2 (en) * 2002-07-17 2010-03-11 Cytos Biotechnology Ag Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
CA2492930C (en) * 2002-07-19 2013-01-08 Cytos Biotechnology Ag Vaccine compositions containing amyloid beta1-6 antigen arrays
WO2006097530A2 (en) * 2005-03-18 2006-09-21 Cytos Biotechnology Ag Cat allergen fusion proteins and uses thereof
US20070184068A1 (en) * 2005-12-14 2007-08-09 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
WO2007113633A2 (en) * 2006-04-03 2007-10-11 Pfizer Products Inc. Immunogenic compositions comprising cat allergen fel dl
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
CA2655108C (en) 2006-06-12 2019-05-07 Cytos Biotechnology Ag Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages
WO2008042789A1 (en) 2006-09-29 2008-04-10 Ligocyte Pharmaceuticals, Inc. Norovirus vaccine formulations
US9388236B2 (en) 2007-07-09 2016-07-12 Nestec Sa Methods for reducing allergies caused by environmental allergens
SI2162133T1 (sl) * 2007-07-09 2016-11-30 Nestec S.A. Postopki za zmanjšanje alergij, ki jih povzročajo alergeni iz okolja
US20100266636A1 (en) 2007-09-18 2010-10-21 Ligocyte Pharmaceuticals, Inc. Method of conferring a protective immune response to norovirus
US10130696B2 (en) 2007-09-18 2018-11-20 Takeda Vaccines, Inc. Method of conferring a protective immune response to norovirus
EP2042193A1 (en) * 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
WO2010017542A1 (en) 2008-08-08 2010-02-11 Ligocyte Pharmaceuticals, Inc. Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
WO2011057134A1 (en) * 2009-11-05 2011-05-12 Novici Biotech Llc Generation of antigenic virus-like particles through protein-protein linkages
US8321012B2 (en) * 2009-12-22 2012-11-27 The Invention Science Fund I, Llc Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject
CA2841356C (en) 2011-07-11 2022-03-01 Takeda Vaccines, Inc. Parenteral norovirus vaccine formulations
MX2014007262A (es) 2011-12-22 2014-08-01 Hoffmann La Roche Sistema de exhibicion de anticuerpos de longitud completa para celulas eucarioticas y su uso.
JO3820B1 (ar) 2012-05-03 2021-01-31 Regeneron Pharma أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها
WO2014066443A1 (en) * 2012-10-23 2014-05-01 Emory University Gm-csf and il-4 conjugates, compositions, and methods related thereto
EP3036543B1 (en) 2013-08-23 2019-06-19 Regeneron Pharmaceuticals, Inc. Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (sit)
US20150175940A1 (en) 2013-12-19 2015-06-25 Nestec Sa Compositions and methods for reducing cat allergens in the environment
MA40824A (fr) * 2014-10-22 2017-08-29 Saiba Gmbh Particules de cmv de type virus modifié
CA3010975A1 (en) 2015-01-15 2016-07-21 University Of Copenhagen Virus-like particle with efficient epitope display
WO2016192788A1 (en) * 2015-06-03 2016-12-08 Universität Zürich Prorektorat Mnw Methods and compositions for preventing and treating cat or dog dander allergy
JP6876682B2 (ja) 2015-09-08 2021-05-26 ウニヴェルズィテート チューリッヒ ネコアレルギーに対する組成物
ES2854726T3 (es) 2015-10-30 2021-09-22 The Univ Of Copenhagen Partícula similar a virus con presentación eficiente de epítopos
CN105219742A (zh) * 2015-11-10 2016-01-06 海南大学 一种展示重组猫致敏原rFel d 1蛋白的免疫增强型病毒样颗粒、其表达载体及其制备与应用
WO2017179025A1 (en) 2016-04-15 2017-10-19 Alk-Abelló A/S Epitope polypeptides of ragweed pollen allergens
FR3054547B1 (fr) * 2016-07-29 2020-06-05 Angany Inc. Particules pseudo-virales et leurs utilisations
US11352417B2 (en) 2016-12-22 2022-06-07 Regeneron Pharmaceuticals, Inc. Method of treating an allergy with allergen-specific monoclonal antibodies
MX2021007285A (es) 2018-12-20 2021-09-23 Saiba AG Particulas similares a virus del cmv modificadas por fusion.
WO2023176206A1 (ja) * 2022-03-18 2023-09-21 デンカ株式会社 リンカーにより連結されたカプシドタンパク質を含むウイルス様粒子
CN114933639B (zh) * 2022-05-05 2023-12-29 中国农业科学院兰州兽医研究所 非洲猪瘟病毒p72N抗原表位蛋白及其制备方法和用途
CN117004650B (zh) * 2023-06-25 2024-05-14 山东立菲生物产业有限公司 一种猫皮屑过敏原组分feld1双链二聚体重组蛋白、制备方法及应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163778A (en) * 1978-05-04 1979-08-07 The Foundation for the Study of Asthma and Related Diseases Asthma immunotherapy
US5374426A (en) * 1986-09-03 1994-12-20 University Of Saskatchewan Rotavirus nucleocapsid protein VP6 in vaccine compositions
JPH03504975A (ja) * 1988-06-14 1991-10-31 セル―エスシーアイ　コーポレイション 異種官能性細胞免疫剤、それを含有するワクチン及びその使用方法
US6120769A (en) * 1989-11-03 2000-09-19 Immulogic Pharmaceutical Corporation Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor
EP0563091A1 (en) 1990-12-20 1993-10-06 SMITHKLINE BEECHAM BIOLOGICALS s.a. Vaccines based on hepatitis b surface antigen
GB9114003D0 (en) * 1991-06-28 1991-08-14 Mastico Robert A Chimaeric protein
GB9213601D0 (en) * 1992-06-26 1992-08-12 Mastico Robert A Protein based delivery system
US6759234B1 (en) * 1994-09-02 2004-07-06 Immulogic Pharmaceutical Corporation Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
AU7726094A (en) 1994-09-02 1996-03-27 Immulogic Pharmaceutical Corporation Peptide compositions capable of down regulating an antigen specific immune response
WO1996030523A2 (en) 1995-03-31 1996-10-03 Hans Wolf Antigen presentation system based on retrovirus-like particles
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
US6054312A (en) * 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
EP1037663A2 (en) * 1997-12-16 2000-09-27 Regents Of The University Of Minnesota Methods to treat undesirable immune responses
AR020102A1 (es) 1998-07-30 2002-04-10 Ucb Sa Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento
WO2000020032A1 (en) 1998-10-06 2000-04-13 Trustees Of Dartmouth College RECOMBINANT CAT ALLERGEN, Fel dI, EXPRESSED IN BACULOVIRUS FOR DIAGNOSIS AND TREATMENT OF CAT ALLERGY
CA2347411C (en) * 1998-10-21 2012-04-03 The Government Of The United States Of America Virus-like particles for the induction of autoantibodies
NZ512456A (en) * 1998-11-30 2003-10-31 Cytos Biotechnology Ag Ordered molecular presentation of antigens
EP1700603A3 (en) 1999-09-25 2007-06-13 Coley Pharmaceutical GmbH Immunostimulatory nucleic acids
CA2407897A1 (en) 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
ATE414773T1 (de) 2000-11-16 2008-12-15 Alk Abello As Mutante allergene
EP1221317A1 (en) * 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
EP1219300B1 (en) 2000-12-28 2006-12-06 BIOMAY Produktions- und Handels- Aktiengesellschaft Treatment of allergies
US7320793B2 (en) 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
JP2005508134A (ja) 2001-03-02 2005-03-31 ザ ロックフェラー ユニヴァーシティ 天然アレルゲンの免疫原性を保持する、アレルゲン性が低下した組み換えハイブリッドアレルゲン構築体
AU2002339224B2 (en) 2001-09-14 2008-10-09 Kuros Us Llc Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
JP4360906B2 (ja) 2001-09-14 2009-11-11 サイトス バイオテクノロジー アーゲー ウィルス様粒子によって誘導される免疫応答を高めるための、抗原提示細胞のインビボでの活性化
BR0213950A (pt) * 2001-11-07 2004-08-24 Cytos Biotechnology Ag Arranjos de antìgenos para o tratamento de doenças eosinofólicas alérgicas
PL369685A1 (pl) * 2001-11-07 2005-05-02 Cytos Biotechnology Ag Układy antygenowe do leczenia choroby kości
AU2003246690B2 (en) * 2002-07-17 2010-03-11 Cytos Biotechnology Ag Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
CN1665565A (zh) 2002-07-19 2005-09-07 赛托斯生物技术公司 Ghrelin－载体偶联物
WO2004018506A2 (en) * 2002-08-22 2004-03-04 Cytos Biotechnology Ag Inducible alphaviral/orip based gene expression system
AU2003275941A1 (en) 2002-11-01 2004-05-25 Alk-Abello A/S Recombinant protein variants
AU2003280324A1 (en) 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
KR20050115913A (ko) * 2003-03-26 2005-12-08 사이토스 바이오테크놀로지 아게 Ｍｅｌａｎ―ａ 펩티드 유사체-바이러스-양-입자컨쥬게이트
EP1620554B1 (en) * 2003-04-24 2008-01-23 Imvision GmbH Recombinant fel d 1 allergen
RU2375076C2 (ru) * 2003-07-10 2009-12-10 Цитос Биотехнологи Аг Укомплектованные вирусоподобные частицы
WO2006097530A2 (en) * 2005-03-18 2006-09-21 Cytos Biotechnology Ag Cat allergen fusion proteins and uses thereof

Also Published As

Publication number Publication date
AU2006224529B2 (en) 2012-05-24
EP1868642B1 (en) 2013-05-08
JP2008535800A (ja) 2008-09-04
BRPI0608455A2 (pt) 2010-01-05
ES2424229T3 (es) 2013-09-30
PL1868642T3 (pl) 2013-10-31
EP1868642A2 (en) 2007-12-26
WO2006097530A3 (en) 2007-06-21
JP5302671B2 (ja) 2013-10-02
CN101141979B (zh) 2013-05-08
US7767212B2 (en) 2010-08-03
CA2599218C (en) 2015-08-11
US20090175896A1 (en) 2009-07-09
JP2013155176A (ja) 2013-08-15
MX2007011160A (es) 2007-11-13
IL185103A0 (en) 2007-12-03
DK1868642T3 (da) 2013-06-24
CY1114171T1 (el) 2016-08-31
NZ561040A (en) 2009-04-30
WO2006097530A2 (en) 2006-09-21
CN101141979A (zh) 2008-03-12
RU2007138265A (ru) 2009-04-27
CA2599218A1 (en) 2006-09-21
US20130344098A1 (en) 2013-12-26
AU2006224529A1 (en) 2006-09-21
KR20070112225A (ko) 2007-11-22
PT1868642E (pt) 2013-07-10
RU2414239C2 (ru) 2011-03-20
CN103203016A (zh) 2013-07-17
US20110045013A1 (en) 2011-02-24

Similar Documents

Publication Publication Date Title
ZA200707413B (en) Cat allergen fusion proteins and uses thereof
IL235620A0 (en) sp35 antibodies and their uses
IL222922A (en) Antibodies against neurophilin-1 and their use
PL1830872T3 (pl) Białka fuzyjne
GB0426397D0 (en) Fusion proteins
IL189246A0 (en) Albumin fusion proteins
LT2650020T (lt) Trimerinio ox40-immunoglobulino sulietas baltymas ir naudojimo būdai
AP2008004471A0 (en) Anti-Alpha2 Intergin antibodies and their uses
EP2007884A4 (en) ENZYMATIC FUSION PROTEINS AND THEIR USE
EP1934372A4 (en) SSB-POLYMERASE HYBRID PROTEINS
IL184024A0 (en) Irta-5 antibodies and their uses
EP1960523A4 (en) MODIFIED POREN FORMING PROTEIN TOXINS AND USE THEREOF
ZA200801224B (en) Albumin fusion proteins
EP1904845A4 (en) IMPROVED RESULTS AND APPLICATION OF COMPARISON EXAMPLES OF PROTEIN EXPRESSIONS
EP1878801A4 (en) Protein splitting method and use thereof
GB0513878D0 (en) Cat allergen
EP1877425A4 (en) FLUORESCENT PROTEINS AND ITS USE
SI1868642T1 (sl) Mačji alergen-fuzijski proteini in njihove uporabe
ZA200808656B (en) Enzyme fusion proteins and their use
IL179998A0 (en) Chimeric proteins and uses thereof
GB0417390D0 (en) Chimeric proteins and uses thereof
HK1082770A1 (en) Supter-antigen fusion proteins and the use thereof
GB0426399D0 (en) Fusion proteins
AU2004901156A0 (en) Cat allergen
AU2004902079A0 (en) Cat allergen